Inactive Instrument
Probi AB Share Price
Stocks
PROB
SE0001280355
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 07/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 31/07/2025 |
James Henson
COO | Chief Operating Officer | 39 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 31/12/2013 |
| Chairman | 62 | 31/03/2015 | |
| Director/Board Member | 64 | 03/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/02/25 | Buy | Company | 142,586 | 1.2514% | ||
| 21/01/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 28/11/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.29% | - | - | 33.68M | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -1.69% | +8.81% | +39.38% | +34.26% | 353B | |
| -0.51% | +3.51% | +36.97% | +43.76% | 301B | |
| +1.50% | +3.40% | +17.71% | +18.77% | 271B | |
| +0.79% | +5.81% | -2.55% | -36.02% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -0.38% | +5.01% | +32.18% | +54.23% | 412.19B | |
| Weighted average by Cap. | -0.50% | +5.02% | +41.92% | +78.83% |
Employees
-
Sector
Pharmaceuticals
